AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 57(3), 1997, pp. 251
Copyright © 1997 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edelman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edelman, R.

Letters to the Editor

Robert Edelman
Center for Vaccine Development University of Maryland at Baltimore 685 West Baltimore Street Baltimore, MD 21201-1509

Dear Sir

We agree with many comments expressed by Dr. F. DeWolfe Miller about our study, High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot study. First, Dr. Miller is correct in stating that he and his collaborators were the first to report the age-specific prevalence of HEV in an Egyptian community. We appreciate his pointing out the 1995 paper by Kamel and others, which we overlooked and should have recognized in our report. Although the serologic profiles by age group differ somewhat between our two study villages, both show serologic evidence of HEV infection in children and high, but reasonably static, seroprevalence rates of HEV among adults. Although we studied fewer villagers, we believe the numbers were sufficient to suggest that the mechanism and dynamics of HEV transmission may be different between the two Nile Delta study villages.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society of Tropical Medicine and Hygiene.